Titles: H.R.1223 — 115th Congress (2017-2018)All Information (Except Text)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

OPEN Act
Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to authorize an extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition, and for other purposes.